Authors
Latest:
Ocrelizumab Wearing-Off Phenomenon: Prevalence, Predictors, and Outcomes After InterventionNearly 25% of people with multiple sclerosis in our study reported wearing off prior to their next ocrelizumab infusion while on the standard 6-month dosing interval.
Latest:
Effect of a Therapeutic Patient Education Program on the Quality of Life of People With Multiple Sclerosis: A Quasi-Experimental StudyPeople with multiple sclerosis who took part in a structured, 4-step therapeutic patient education program exhibited improved mental quality of life, better understanding of their disease, and reduced anxiety and depression.
Latest:
Tumefactive Demyelination in Older Adults: Diagnosis and MisdiagnosisAlthough more common in younger patients, tumefactive demyelination can occur in adults 65 years and older. It should be considered as a differential diagnosis in patients of this age presenting with a central nervous system lesion.
Latest:
Attitudes of Neurologists Toward the Potential Role of Serum Neurofilament Light Chain Measurement in Treatment Decision-Making for People With Radiologically Isolated SyndromeSerum neurofilament light chain measurement can help identify individuals with radiologically isolated syndrome who are at high risk for multiple sclerosis conversion.